Only about one-third of approved Foods with Function Claims (FFC) made it on to the market in FY2021, with more than 60 per cent pending launch, exclusive new data has shown.
The quality of clinical trials behind products under Japan’s Foods with Function Claims (FFCs) is undermined by a lack of proper protocols, such as the absence of trial registration and transparent study designs, says a new study.
